F. Hoffmann-La Roche. at Hoffmann-La RocheSpeaker
Agenda Sessions
Presentation: The Promise Of Signal-biased Dual GLP-1/GIP Agonist Enicepatide in Weight Management
, 10:55View Session
Presentation: The Promise Of Signal-biased Dual GLP-1/GIP Agonist Enicepatide in Weight Management